Andrew Turitz - 31 May 2024 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
EVP, CORPORATE DEVELOPMENT
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol
TDOC
Transactions as of
31 May 2024
Net transactions value
-$18,152
Form type
4
Filing time
04 Jun 2024, 16:06:56 UTC
Previous filing
20 Mar 2024
Next filing
04 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +1,056 +3.1% 34,838 31 May 2024 Direct F1
transaction TDOC Common Stock Options Exercise +1,348 +3.9% 36,186 31 May 2024 Direct F2
transaction TDOC Common Stock Options Exercise +3,100 +8.6% 39,286 31 May 2024 Direct F2
transaction TDOC Common Stock Sale $18,152 -1,627 -4.1% $11.16 37,659 03 Jun 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Performance Stock Units Options Exercise $0 -1,056 -12% $0.000000 7,397 31 May 2024 Common Stock 1,056 Direct F1, F4
transaction TDOC Restricted Stock Units Options Exercise $0 -1,348 -25% $0.000000 4,044 31 May 2024 Common Stock 1,348 Direct F2, F5
transaction TDOC Restricted Stock Units Options Exercise $0 -3,100 -12% $0.000000 21,702 31 May 2024 Common Stock 3,100 Direct F2, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F3 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4 On March 1, 2024, the reporting person earned 12,679 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F5 On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F6 On March 3, 2023, the reporting person was granted 37,202 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.